- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Rapid Dose Therapeutics Corp.: Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt | 275 | Newsfile | Burlington, Ontario--(Newsfile Corp. - January 5, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that pursuant to the terms of its amended and restated... ► Artikel lesen | |
| 09.12.25 | Rapid Dose Therapeutics Corp.: Rapid Dose Completes Extension to Promissory Notes | 312 | Newsfile | Burlington, Ontario--(Newsfile Corp. - December 8, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that it has extended the maturity date of its outstanding... ► Artikel lesen | |
| 29.11.25 | Rapid Dose Therapeutics Corp: Rapid Dose to extend note maturity date | 3 | Stockwatch | ||
| 29.11.25 | Rapid Dose Therapeutics Corp.: Rapid Dose Announces Extension to Promissory Notes | 463 | Newsfile | Burlington, Ontario--(Newsfile Corp. - November 28, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that it intends to extend the maturity date of its outstanding... ► Artikel lesen | |
| 18.11.25 | CEO.CA Technologies Ltd.: CEO.CA's Inside the Boardroom: Rapid Dose Therapeutics Extends NicStrip Deal with Nicotine Partner as Health Canada Reviews Product | 358 | Newsfile | Toronto, Ontario--(Newsfile Corp. - November 18, 2025) - CEO.CA ("CEO.CA"), the leading investor social network in venture stocks, shares exclusive updates with CEOs and executives from around the... ► Artikel lesen | |
| 21.10.25 | PTA-News: Rapid Dose Therapeutics Inc.: Rapid Dose Therapeutics veröffentlicht Update zum Nikotingeschäft und verlängert die Zusammenarbeit - mit einem internationalem Nikotinpartner um sieben Monate. | 376 | Dow Jones News | DJ PTA-News: Rapid Dose Therapeutics Inc.: Rapid Dose Therapeutics veröffentlicht Update zum Nikotingeschäft und verlängert die Zusammenarbeit - mit einem internationalem Nikotinpartner um sieben... ► Artikel lesen | |
| 21.10.25 | Rapid Dose Therapeutics Corp: Rapid Dose extends precommercialization nicotine deal | 3 | Stockwatch | ||
| RAPID DOSE THERAPEUTICS Aktie jetzt für 0€ handeln | |||||
| 20.10.25 | Rapid Dose Therapeutics Corp.: Rapid Dose Therapeutics Releases Nicotine Business Update and Extends Collaboration with International Nicotine Partner | 395 | Newsfile | Burlington, Ontario--(Newsfile Corp. - October 20, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian life sciences company developing innovative drug delivery solutions... ► Artikel lesen | |
| 03.10.25 | Rapid Dose Therapeutics Corp: Rapid Dose pays debt interest with 592,533 shares | 2 | Stockwatch | ||
| 02.10.25 | Rapid Dose Therapeutics Corp.: Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt | 436 | Newsfile | Burlington, Ontario--(Newsfile Corp. - October 2, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that as contemplated in the secured convertible notes (the... ► Artikel lesen | |
| 04.08.25 | Rapid Dose Therapeutics Corp.: Rapid Dose Therapeutics Submits QuickStrip Nicotine Product for Health Canada Approval | 482 | Newsfile | Burlington, Ontario--(Newsfile Corp. - August 4, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian life sciences company focused on innovative drug delivery technologies... ► Artikel lesen | |
| 29.07.25 | Rapid Dose Therapeutics Corp: Rapid Dose, Eco work on harm reduction pilot project | 2 | Stockwatch | ||
| 29.07.25 | Rapid Dose Therapeutics Corp.: Rapid Dose Therapeutics and Eco Canadian Organic Inc. Initiate Health Canada Funded SUAP Harm Reduction Pilot Project on First Nations Using QuickStrip to Combat Opiate Addiction Crisis | 242 | Newsfile | Burlington, Ontario--(Newsfile Corp. - July 29, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian biotechnology company, is proud to announce the launch of a new... ► Artikel lesen | |
| 22.07.25 | CEO.CA Technologies Ltd.: CEO.CA's Inside the Boardroom: QuickStrip Technology - How Rapid Dose Is Changing The Way We Take Medicine | 628 | Newsfile | Toronto, Ontario--(Newsfile Corp. - July 22, 2025) - CEO.CA ("CEO.CA"), the leading investor social network in venture stocks, shares exclusive updates with CEOs and executives from around the globe.Founded... ► Artikel lesen | |
| 03.07.25 | Rapid Dose Therapeutics Corp.: Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt | 552 | Newsfile | Burlington, Ontario--(Newsfile Corp. - July 3, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that as contemplated in the secured convertible notes (the... ► Artikel lesen | |
| 03.07.25 | Rapid Dose Therapeutics Corp.: Rapid Dose Announces Proposed Issuance of Shares as Payment of Director Fees | 676 | Newsfile | Burlington, Ontario--(Newsfile Corp. - July 3, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announces that it has agreed with its non-management directors (the "Directors")... ► Artikel lesen | |
| 02.07.25 | CEO.CA Technologies Ltd.: CEO.CA's Inside the Boardroom: Rapid Dose's Drug Delivery Tech in NFL-Funded Study | 355 | Newsfile | Toronto, Ontario--(Newsfile Corp. - July 2, 2025) - CEO.CA ("CEO.CA"), the leading investor social network in venture stocks, shares exclusive updates with CEOs and executives from around the globe.Founded... ► Artikel lesen | |
| 02.06.25 | Rapid Dose Therapeutics Corp.: Rapid Dose Announces Completion of Share Issuance in Debt Settlement with Creditors | 410 | Newsfile | Burlington, Ontario--(Newsfile Corp. - June 2, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced that further to its press release dated May 10, 2025, it has... ► Artikel lesen | |
| 28.05.25 | PTA-News: Rapid Dose Therapeutics Inc.: Partnerschaft mit weltweit führendem Tabakhersteller | 384 | Dow Jones News | DJ PTA-News: Rapid Dose Therapeutics Inc.: Partnerschaft mit weltweit führendem Tabakhersteller
Unternehmensmitteilung für den Kapitalmarkt
Rapid Dose Therapeutics Inc.: Partnerschaft mit... ► Artikel lesen | |
| 28.05.25 | Rapid Dose Therapeutics Corp.: Partnerschaft mit weltweit führendem Tabakhersteller | 509 | IR-WORLD | BURLINGTON, ON - 26. Mai 2025 - Rapid Dose Therapeutics Corp. ("RDT" oder das "Unternehmen") (CSE: DOSE), ein kanadisches Biowissenschaftsunternehmen, das sich
auf innovative Lösungen für die... ► Artikel lesen |
1 2 Weiter >>
34 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BIONTECH | 85,60 | +0,88 % | BioNTech-Aktie: Ein guter Kauf für 2026? | Seit Anfang Dezember 2025 tritt die BioNTech-Aktie bei Kursen um die 96 US$ auf der Stelle. Auch zum Jahresstart zeigt sie wenig Bewegung. Sehen Anleger hier keine guten Investmentchancen für 2026?... ► Artikel lesen | |
| CORE ONE LABS | - | - | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 22.09.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 22.09.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 22.09.2025ISIN NameAU000000PEK2 PEAK... ► Artikel lesen | |
| BIONXT SOLUTIONS | 0,385 | +1,05 % | Revolutionäre Fortschritte: BioTech-Ideen für 2026! Bayer, Novo Nordisk, BioNxt, Vidac, BioNTech und Evotec! | Trotz eines schwierigen Umfelds 2025 bleibt der Biotech-Sektor fundamental attraktiv, da der medizinische Fortschritt nicht zum Stillstand kommt. Der rasante Einsatz von Künstlicher Intelligenz und... ► Artikel lesen | |
| CLINUVEL | 7,355 | +1,10 % | CLINUVEL PHARMACEUTICALS LIMITED: SCENESSE efficacy in vitiligo - new cases presented at RDTC | ||
| VIDAC PHARMA | 0,666 | +12,88 % | So profitieren Sie 2026 vom Comeback der Gesundheitsbranche: Novo Nordisk, Vidac Pharma und Pfizer im Fokus | Nachdem das letzte Jahr für Investoren der Pharma- und Biotech-Branche eine Enttäuschung war, wendet sich das Blatt an der Börse für diese Werte aktuell entscheidend. Politische Klarheit, eine Rückkehr... ► Artikel lesen | |
| ATAIBECKLEY | 3,745 | -5,67 % | XFRA B72: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILATAIBECKLEY INC.... ► Artikel lesen | |
| SOL GLOBAL INVESTMENTS | 0,008 | +1,20 % | SOL Global Investments Corp.: SOL Global Announces Share Consolidation | Toronto, Ontario--(Newsfile Corp. - December 8, 2025) - SOL Global Investments Corp. (CSE: SOL) (OTCID: SOLCF) (FSE: 9SB) ("SOL" or the "Company") announces that a majority vote by its Board of Directors... ► Artikel lesen | |
| ENTHEON BIOMEDICAL CORP | 0,045 | +1,12 % | Entheon Biomedical Corp.: Entheon Announces Letter of Intent with Nutravisor Inc. | Vancouver, British Columbia--(Newsfile Corp. - December 22, 2025) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU) ("Entheon" or the "Company") is pleased to announce that it has... ► Artikel lesen | |
| MUSTGROW BIOLOGICS | 0,356 | -9,64 % | MustGrow Biologics Corp.: MustGrow Announces Non-Brokered LIFE Offering of up to $2 Million | Saskatoon, Saskatchewan--(Newsfile Corp. - January 8, 2026) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow") is pleased to announce a non-brokered... ► Artikel lesen | |
| CYBIN | 6,450 | +1,57 % | Cybin Inc (2): Cybin starts trading on Nasdaq | ||
| TVARDI THERAPEUTICS | 3,581 | -1,49 % | Faruqi & Faruqi LLP: INVESTIGATION ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics | Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Tvardi To Contact Him Directly To Discuss Their OptionsIf you suffered... ► Artikel lesen | |
| REVIVE THERAPEUTICS | 0,001 | -95,00 % | Revive Therapeutics Ltd.: Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study | TORONTO, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company focused on the research... ► Artikel lesen | |
| ARTELO BIOSCIENCES | 1,410 | -11,88 % | Artelo Biosciences Affirms Strong Partnering Outlook for ART27.13 Following Positive Interim Phase 2 CAReS Results | SOLANA BEACH, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop... ► Artikel lesen | |
| LOBE SCIENCES | 0,033 | +38,30 % | Lobe Sciences Ltd.: Lobe Sciences Reports FY2025 with a Stronger Balance Sheet and Sharpened Strategy | Balance Sheet and Sharpened Strategy VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / January 8, 2026 / Lobe Sciences Ltd. (CSE:LOBE)(OTCQB:LOBEF)(Frankfurt:LOBE.F) ("Lobe" or the "Company"), a biopharmaceutical... ► Artikel lesen | |
| MOONLAKE IMMUNOTHERAPEUTICS | 18,610 | +29,69 % | MoonLake Immunotherapeutics AG: MoonLake Immunotherapeutics Announces Positive Outcome from Type B Meeting with U.S. FDA and Announces Investor Day | MoonLake requested a Type B meeting with the U.S. Food and Drug Administration (FDA) to obtain regulatory clarity and discuss the clinical evidence strategy for submission of a Biologic License Application... ► Artikel lesen |
Das Unternehmen RAPID DOSE THERAPEUTICS CORP kann der Branche Biotechnologie zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu RAPID DOSE THERAPEUTICS CORP finden Sie auf Wallstreet Online.